Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

[The Swedish Transport Agency's regulations and general guidelines: More opinions than science for patients with type 1 diabetes].

Lehtihet M, Adner N, Sjöholm A, Calissendorff J, Berggren LJ, Kihlman J.

Lakartidningen. 2012 Nov 28-Dec 4;109(48):2229-30; discussion 2230. Swedish. No abstract available.

PMID:
23330532
2.

Primary hyperparathyroidism in pregnancy: a diagnostic and therapeutic challenge.

Nilsson IL, Adner N, Reihnér E, Palme-Kilander C, Edstrom G, Degerblad M.

J Womens Health (Larchmt). 2010 Jun;19(6):1117-21. doi: 10.1089/jwh.2009.1777.

PMID:
20469964
3.

Apligraf in the treatment of neuropathic diabetic foot ulcers.

Edmonds M; European and Australian Apligraf Diabetic Foot Ulcer Study Group.

Int J Low Extrem Wounds. 2009 Mar;8(1):11-8. doi: 10.1177/1534734609331597. Epub 2009 Feb 3.

PMID:
19189997
4.

Predictors of cognitive impairment in type 1 diabetes.

Brismar T, Maurex L, Cooray G, Juntti-Berggren L, Lindström P, Ekberg K, Adner N, Andersson S.

Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1041-51. Epub 2007 Sep 19.

PMID:
17884300
5.

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

Näslund E, King N, Mansten S, Adner N, Holst JJ, Gutniak M, Hellström PM.

Br J Nutr. 2004 Mar;91(3):439-46.

PMID:
15005830
6.

Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.

Ahrén B, Adner N, Svartberg J, Petrella E, Holst JJ, Gutniak MK.

Diabet Med. 2002 Sep;19(9):790-2. No abstract available.

PMID:
12207819
8.

Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes.

Gutniak MK, Svartberg J, Hellström PM, Holst JJ, Adner N, Ahrén B.

J Intern Med. 2001 Jul;250(1):81-7.

9.
10.

Persons with insulin-dependent diabetes mellitus: acceptance and coping ability.

Richardson A, Adner N, Nordström G.

J Adv Nurs. 2001 Mar;33(6):758-63.

PMID:
11298213
12.

Inhibition of melatonin secretion by ethanol in man.

Röjdmark S, Wikner J, Adner N, Andersson DE, Wetterberg L.

Metabolism. 1993 Aug;42(8):1047-51.

PMID:
8345809
14.

Collaborative study of a control standard endotoxin using the Limulus amebocyte (gel-clot) test.

Adner N, Flink O, Nystrand R, Pihl B, Vegis P.

J Parenter Sci Technol. 1991 Mar-Apr;45(2):88-93.

PMID:
2051262
15.

Insulin sensitivity in alcoholics in a withdrawal state.

Adner N, Nygren A.

J Intern Med. 1990 Jul;228(1):59-64.

PMID:
2200838
18.

Biological responses of sheep treated with endotoxin-contaminated superoxide dismutase and endotoxin preparations.

Yagoda CR, Bylund-Fellenius AC, Adner N, Kindahl H.

Acta Vet Scand. 1990;31(2):207-17.

PMID:
2260514
19.

Insulin secretion in alcoholics in a withdrawal state.

Adner N, Nygren A.

Acta Med Scand. 1986;219(2):201-7.

PMID:
3515866
20.

Insulin uptake by the human alcoholic cirrhotic liver.

Nygren A, Adner N, Sundblad L, Wiechel KL.

Metabolism. 1985 Jan;34(1):48-52.

PMID:
3880856

Supplemental Content

Loading ...
Support Center